Accueil>>Analytical Standards>>ADB-HEXINACA N-hexanoic acid metabolite

ADB-HEXINACA N-hexanoic acid metabolite

Catalog No.GC49645

An Analytical Reference Standard

Products are for research use only. Not for human use. We do not sell to patients.

ADB-HEXINACA N-hexanoic acid metabolite Chemical Structure

Cas No.: N/A

Taille Prix Stock Qté
1 mg
199,00 $US
En stock
5 mg
745,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ADB-HEXINACA N-hexanoic acid metabolite is an analytical reference standard that is structurally similar to known synthetic cannabinoids. ADB-HEXINACA N-hexanoic acid metabolite is a potential metabolite of ADB-HEXINACA based on the published metabolism of ADB-PINACA .1 At the time ADB-HEXINACA N-hexanoic acid metabolite was made available for purchase, specific metabolism data had not been published. Contact us if updated information on this molecule is now available. This product is intended for research and forensic applications.

1.Franz, F., Jechle, H., Wilde, M., et al.Structure-metabolism relationships of valine and tert-leucine-derived synthetic cannabinoid receptor agonists: A systematic comparison of the in vitro phase I metabolism using pooled human liver microsomes and high-resolution mass spectrometryForensic Toxicol.37316-329(2019)

Avis

Review for ADB-HEXINACA N-hexanoic acid metabolite

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ADB-HEXINACA N-hexanoic acid metabolite

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.